Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02542514 |
|---|---|
| Brief Title: | Study of Ibrutinib in Patients With Relapsed or Refractory Primary Central Nervous Lymphoma or Intraocular Lymphoma (iLOC) |
| First Submitted : | August 31, 2015 |
| First Submitted that Met QC Criteria : | September 4, 2015 |
| First Posted : | September 7, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | April 6, 2022 |
| Last Update Posted : | April 14, 2022 |